Diagnosis and Natural History of HIV-Associated Nephropathy

Advances in Chronic Kidney Disease

Volumn 17, Issue 1, 2010, Pages 52-58

  Atta, Mohamed G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ESRD; HAART; HIV 1; HIV associated nephropathy; Kidney

Indexed keywords

CORTICOSTEROID;

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; KIDNEY DISEASE; KIDNEY FAILURE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

AIDS-ASSOCIATED NEPHROPATHY; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV-1; HUMANS; KIDNEY FAILURE, CHRONIC; RISK FACTORS; WORLD HEALTH;

EID: 71249145352     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2009.08.005     Document Type: Review

References (64)

1. Gardenswartz M.H., Lerner C.W., Seligson G.R., et al. Renal disease in patients with AIDS: A clinicopathologic study. Clin Nephrol 21 (1984) 197-204
2. Pardo V., Aldana M., Colton R.M., et al. Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med 101 (1984) 429-434
3. Rao T.K., Filippone E.J., Nicastri A.D., et al. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 310 (1984) 669-673
4. Mazbar S.A., Schoenfeld P.Y., and Humphreys M.H. Renal involvement in patients infected with HIV: Experience at San Francisco General Hospital. Kidney Int 37 (1990) 1325-1332
5. Ross M.J., and Klotman P.E. Recent progress in HIV-associated nephropathy. J Am Soc Nephrol 13 (2002) 2997-3004
6. Carbone L., D'Agati V., Cheng J.T., et al. Course and prognosis of human immunodeficiency virus-associated nephropathy. Am J Med 87 (1989) 389-395
7. Cantor E.S., Kimmel P.L., and Bosch J.P. Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy. Arch Intern Med 151 (1991) 125-128
8. Laradi A., Mallet A., Beaufils H., et al. HIV-associated nephropathy: outcome and prognosis factors. Groupe d' Etudes Nephrologiques d'Ile de France. J Am Soc Nephrol 9 (1998) 2327-2335
9. Williams D.I., Williams D.J., Williams I.G., et al. Presentation, pathology, and outcome of HIV associated renal disease in a specialist centre for HIV/AIDS. Sex Transm Infect 74 (1998) 179-184
10. Abbott K.C., Hypolite I., Welch P.G., et al. Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: Patient characteristics and survival in the pre highly active antiretroviral therapy era. J Nephrol 14 (2001) 377-383
11. Kopp J.B., and Winkler C. HIV-associated nephropathy in African Americans. Kidney Int Suppl 83 (2003) S43-S49
12. Eggers P.W., and Kimmel P.L. Is there an epidemic of HIV Infection in the US ESRD program?. J Am Soc Nephrol 15 (2004) 2477-2485
13. Shahinian V., Rajaraman S., Borucki M., et al. Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients. Am J Kidney Dis 35 (2000) 884-888
14. Nochy D., Glotz D., Dosquet P., et al. Renal disease associated with HIV infection: A multicentric study of 60 patients from Paris hospitals. Nephrol Dial Transplant 8 (1993) 11-19
15. Nochy D., Glotz D., Dosquet P., et al. Renal lesions associated with human immunodeficiency virus infection: North American vs. European experience. Adv Nephrol Necker Hosp 22 (1993) 269-286
16. Lucas G.M., Mehta S.H., Atta M.G., et al. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS 21 (2007) 2435-2443
17. Bruggeman L.A., Ross M.D., Tanji N., et al. Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 11 (2000) 2079-2087
18. Gharavi A.G., Ahmad T., Wong R.D., et al. Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. Proc Natl Acad Sci U S A 101 (2004) 2488-2493
19. Papeta N., Chan K.T., Prakash S., et al. Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expression. J Clin Invest 119 (2009) 1178-1188
20. Kopp J.B., Smith M.W., Nelson G.W., et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 40 (2008) 1175-1184
21. Winston J.A., Bruggeman L.A., Ross M.D., et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 344 (2001) 1979-1984
22. Szabo S., James C.W., and Telford G. Unusual presentations of primary human immunodeficiency virus infection. AIDS Patient Care STDS 16 (2002) 251-254
23. Izzedine H., Wirden M., and Launay-Vacher V. Viral load and HIV-associated nephropathy. N Engl J Med 353 (2005) 1072-1074
24. Estrella M., Fine D.M., Gallant J.E., et al. HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients. Clin Infect Dis 43 (2006) 377-380
25. Zhong J., Zuo Y., Ma J., et al. Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int 68 (2005) 1048-1060
26. He J.C., Husain M., Sunamoto M., et al. Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. J Clin Invest 114 (2004) 643-651
27. Hanna Z., Kay D.G., Rebai N., et al. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95 (1998) 163-175
28. Hanna Z., Kay D.G., Cool M., et al. Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease. J Virol 72 (1998) 121-132
29. Zuo Y., Matsusaka T., Zhong J., et al. HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis. J Am Soc Nephrol 17 (2006) 2832-2843
30. Marras D., Bruggeman L.A., Gao F., et al. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med 8 (2002) 522-526
31. Lu T.-C., He J.C., Wang Z.-H., et al. HIV-1 nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein. J Biol Chem 283 (2008) 8173-8182
32. Conaldi P.G., Bottelli A., Baj A., et al. Human immunodeficiency virus-1 tat induces hyperproliferation and dysregulation of renal glomerular epithelial cells. Am J Pathol 161 (2002) 53-61
33. Wali R.K., Drachenberg C.I., Papadimitriou J.C., et al. HIV-1-associated nephropathy and response to highly-active antiretroviral therapy. Lancet 352 (1998) 783-784
34. Lucas G.M., Eustace J.A., Sozio S., et al. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: A 12-year cohort study. AIDS 18 (2004) 541-546
35. Atta M.G., Gallant J.E., Rahman M.H., et al. Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol Dial Transplant 21 (2006) 2809-2813
36. Scialla J.J., Atta M.G., and Fine D.M. Relapse of HIV-associated nephropathy after discontinuing highly active antiretroviral therapy. AIDS 21 (2007) 263-264
37. Winston J.A., Klotman M.E., and Klotman P.E. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int 55 (1999) 1036-1040
38. Levin M.L., Palella F., Shah S., et al. HIV-associated nephropathy occurring before HIV antibody seroconversion. Am J Kidney Dis 37 (2001) E39
39. Ross M.J., Klotman P.E., and Winston J.A. HIV-associated nephropathy: Case study and review of the literature. AIDS Patient Care STDS 14 (2000) 637-645
40. Berliner A.R., Fine D.M., Lucas G.M., et al. Observations on a cohort of HIV-infected patients undergoing native renal biopsy. Am J Nephrol 28 (2008) 478-486
41. Han T.M., Naicker S., Ramdial P.K., et al. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int 69 (2006) 2243-2250
42. D'Agati V., Suh J.I., Carbone L., et al. Pathology of HIV-associated nephropathy: A detailed morphologic and comparative study. Kidney Int 35 (1989) 1358-1370
43. D'Agati V., and Appel G.B. HIV infection and the kidney. J Am Soc Nephrol 8 (1997) 138-152
44. Albaqumi M., Soos T.J., Barisoni L., et al. Collapsing glomerulopathy. J Am Soc Nephrol 17 (2006) 2854-2863
45. Post F.A., Campbell L.J., Hamzah L., et al. Predictors of renal outcome in HIV-associated nephropathy. Clin Infect Dis 46 (2008) 1282-1289
46. Atta M.G., Longenecker J.C., Fine D.M., et al. Sonography as a predictor of human immunodeficiency virus-associated nephropathy. J Ultrasound Med 23 (2004) 603-610
47. Atta M.G., Choi M.J., Longenecker J.C., et al. Nephrotic range proteinuria and CD4 count as noninvasive indicators of HIV-associated nephropathy. Am J Med 118 (2005) 1288.e1221-1288.e1226
48. Eustace J.A., Nuermberger E., Choi M., et al. Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids. Kidney Int 58 (2000) 1253-1260
49. Burns G.C., Paul S.K., Toth I.R., et al. Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy. J Am Soc Nephrol 8 (1997) 1140-1146
50. Smith M.C., Austen J.L., Carey J.T., et al. Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy. Am J Med 101 (1996) 41-48
51. Briggs W.A., Tanawattanacharoen S., Choi M.J., et al. Clinicopathologic correlates of prednisone treatment of human immunodeficiency virus-associated nephropathy. Am J Kidney Dis 28 (1996) 618-621
52. Burns G.C., Matute R., Onyema D., et al. Response to inhibition of angiotensin-converting enzyme in human immunodeficiency virus-associated nephropathy: A case report. Am J Kidney Dis 23 (1994) 441-443
53. Hammer S.M., Eron Jr. J.J., Reiss P., et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA 300 (2008) 555-570
54. He J.C., Lu T.C., Fleet M., et al. Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway. J Am Soc Nephrol 18 (2007) 93-102
55. Available at: http://www.hivtransplant.com/. Accessed May 28, 2009
56. Rao T.K., Friedman E.A., and Nicastri A.D. The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 316 (1987) 1062-1068
57. Szczech L.A., Gupta S.K., Habash R., et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 66 (2004) 1145-1152
58. Ortiz C., Meneses R., Jaffe D., et al. Outcome of patients with human immunodeficiency virus on maintenance hemodialysis. Kidney Int 34 (1988) 248-253
59. Tebben J.A., Rigsby M.O., Selwyn P.A., et al. Outcome of HIV infected patients on continuous ambulatory peritoneal dialysis. Kidney Int 44 (1993) 191-198
60. Ahuja T.S., Grady J., and Khan S. Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. J Am Soc Nephrol 13 (2002) 1889-1893
61. Macrae J., Friedman A.L., Eggers P., et al. Improved survival in HIV-infected African-Americans with ESRD. Clin Nephrol 64 (2005) 124-128
62. Atta M.G., Fine D.M., Kirk G.D., et al. Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland. Clin Infect Dis 45 (2007) 1625-1632
63. US Renal Data System (USRDS): 2006 Annual Data Report: National Institutes of Health, National Institute of Diabetes and Digestive Diseases and Kidney Diseases, Bethesda, MD. http://www.usrds.org Accessed January 8, 2008
64. Ahuja T.S., Borucki M., Funtanilla M., et al. Is the prevalence of HIV-associated nephropathy decreasing?. Am J Nephrol 19 (1999) 655-659